Skip to content

Bausch + Lomb CX4320

by Bausch & Lomb Incorporated

Bausch + Lomb CX4320 is a phacoemulsification/vitrectomy system (FDA Class II; FDA product code HQC, Unit, Phacofragmentation) made by Bausch & Lomb Incorporated, listed in FDA GUDID since 7 Nov 2016 (UDI-DI 10757770056948), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10757770056948 UDI-DI Date7 Nov 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Micro Incision Premium Venturi Pack
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Bausch + Lomb
Generic name
Phacoemulsification/vitrectomy system
Model / Ref / Catalog
CX4320
Primary DI / UDI-DI
10757770056948
FDA product code
HQC
GMDN term
Phacoemulsification/vitrectomy system
Device class
Class II
Regulation number
886.4670
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Phacoemulsification/vitrectomy system.

Other devices from Bausch & Lomb Incorporated

See all devices from Bausch & Lomb Incorporated →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)